0 items USD 0.00Search
Your search for "delveinsight antibody drug conjugate insight pipeline assessment technology trend competitive" gave back 220442 results.
The report entitled „Antibody-Drug Conjugates 2014 – A Business, Technology & Pipeline Analysis“ published in January 2014 is based on the...
Catalog:
La Merie Publishing
January 2014
Price: USD 2,298.00
This report describes and analyzes the situation of antibody-drug conjugates as of November 2015 regarding: ADC pipeline, ADC technologies, ADC...
Catalog:
La Merie Publishing
November 2015
Price: USD 2,500.00
Antibody-Drug Conjugate Pipeline Review by target, drug, phase and company The competitive intelligence report „ Antibody-Drug Conjugate Pipeline...
Catalog:
La Merie Publishing
December 2016
Price: USD 880.00
Anti-Her2 Antibody-Drug Conjugates in: September 2016 R&D and Business Tracker for Antibody-Drug Conjugates This pdf report contains information...
Catalog:
La Merie Publishing
October 2016
Price: USD 225.00
Subscription to La Merie Publishing's proprietary Antibody Database provides online access to information about more than 6,231 project entries for...
Catalog:
La Merie Publishing
August 2023
Price: USD 1,760.00
This report bundle includes four reports about novel cancer targets which have in common a compelling target expression profile with a low risk of on...
Catalog:
La Merie Publishing
July 2022
Price: USD 2,000.00
This pdf report contains information about Antibody-Drug Conjugates (ADCs) released during the month of October 2016. Featured presentations of...
Catalog:
La Merie Publishing
November 2016
Price: USD 225.00
Biosimilar and Biosuperior Therapeutic Antibodies 2014 The present Competitive Intelligence Report about Biosimilar and Biosuperior Therapeutic...
Catalog:
La Merie Publishing
March 2014
Price: USD 1,514.00
This report provides you with a landscape description and analysis of discovery and development of claudin 18.2 (CLDN18.2)-targeted antibody and cell...
Catalog:
La Merie Publishing
August 2023
Price: USD 2,365.00
“ IMMUNE CHECKPOINT THERAPEUTICS – HOT TARGETS & PIPELINE ANALYSIS ” gives comprehensive insights on the various Immune Checkpoint modulators...
Catalog:
IQ4I
April 2016
Price: USD 4,500.00
This report evaluates Receptor tyrosine kinase-like Orphan Receptor 1 (ROR1) from an industry perspective for its suitability as a tumor-specific...
Catalog:
La Merie Publishing
June 2022
Price: USD 1,170.00
The present Competitive Intelligence Report about Her2 Antibodies - Trastuzumab Biosimilars and Biobetters/Biosuperiors provides a competitor...
Catalog:
La Merie Publishing
February 2014
Price: USD 413.00
This Competitive Intelligence Report about Therapeutic Antibodies 2015: Biosimilars & Biosuperiors provides a competitor evaluation in the field...
Catalog:
La Merie Publishing
April 2015
Price: USD 1,500.00
The global Antibody-radionuclide Conjugates market size was valued at US$ 1020.1 million in 2022. With growing demand in downstream market, the...
Catalog:
LPI
December 2023
Price: USD 3,660.00
This Competitive Intelligence Report about EGF-R Antibodies 2015 – Biosuperiors and Biosimilars of Erbitux provides a competitor evaluation in the...
Catalog:
La Merie Publishing
March 2015
Price: USD 288.00
